Marathon Asset Management closed on a $165 million preferred equity investment in Healogics LLC, an outsourced operator of wound care centers in U.S. hospitals.
The new investment from the $22 billion global credit firm positions Healogics for growth, officials said.
“We are thrilled to partner with Healogics through this investment,” said Randy Raisman, managing director in Marathon Asset Management’s Capital Solutions Group, who will be joining Healogics’ board of directors as an observer. “We believe that Healogics has solid growth prospects going-forward driven by several industry tailwinds, including growth in the diabetic . . .
Continue Reading
Unlock this article instantly, along with the rest of our premium content and daily, weekly and monthly newsletters. We offer pay-as-you-go monthly subscriptions and discounted annual subscriptions with additional benefits: access to Alternatives Watch Research articles and our Annual Investor Compendium.
